Production (Stage)
Inspire Medical Systems, Inc.
INSP
$143.21
-$2.74-1.88%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 66.51M | 53.51M | 33.05M | 6.01M | -15.73M |
| Total Depreciation and Amortization | 8.76M | 6.55M | 4.89M | 3.82M | 3.09M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 115.59M | 107.90M | 101.11M | 95.56M | 88.14M |
| Change in Net Operating Assets | -76.17M | -37.71M | -60.72M | -75.70M | -40.64M |
| Cash from Operations | 114.68M | 130.25M | 78.33M | 29.69M | 34.86M |
| Capital Expenditure | -35.83M | -39.12M | -40.13M | -39.11M | -31.57M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -59.31M | -74.00M | -228.48M | -270.77M | -279.03M |
| Cash from Investing | -95.14M | -113.12M | -268.61M | -309.88M | -310.60M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 30.60M | 27.77M | 30.60M | 20.39M | 27.35M |
| Repurchase of Common Stock | -171.52M | -80.17M | -22.97M | -19.15M | -18.26M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -140.92M | -52.39M | 7.63M | 1.24M | 9.09M |
| Foreign Exchange rate Adjustments | -156.00K | -118.00K | 259.00K | -64.00K | -56.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -121.53M | -35.39M | -182.39M | -279.02M | -266.72M |